Association Between MC-2 Peptide and Hepatic Perfusion and Liver Injury Following Resuscitated Hemorrhagic Shock.

Authors:

Abstract
Hemorrhagic shock (HS) due to trauma is the third most common cause of death worldwide and the leading cause of death in people aged 1 to 44 years.1-3 The roles of the gut and liver in the progression to multiple organ failure (MOF) are not clear.4,5 Downmodulation of the systemic inflammatory process during resuscitation might be beneficial in the treatment of HS.6,7 We examined the ability of a novel peptide, MC-2, to inhibit proinflammatory cytokines, prevent edema, and improve hepatic perfusion in an experimental model of resuscitated HS.

This publication has 32 references indexed in Scilit: